Age-related macular degeneration : vimarsana.com

Age-related macular degeneration is an increasingly important public health issue
due to ageing populations and increased longevity. Age-related macular degeneration
affects individuals older than 55 years and threatens high-acuity central vision required
for important tasks such as reading, driving, and recognising faces. Advances in retinal
imaging have identified biomarkers of progression to late age-related macular degeneration.
New treatments for neovascular age-related macular degeneration offer potentially
longer-lasting effects, and progress is being made towards a treatment for atrophic
late age-related macular degeneration.

Related Keywords

Wisconsin , United States , London , City Of , United Kingdom , Australia , Philadelphia , Pennsylvania , Israel , South Korea , Scotland , Han , El Mehdi , Malattia Leventinese , Quezada Ruiz , Acta Ophthalmol , Oliveira Dias , Semin Ophthalmol , Clin Ophthalmol , Nat Genet , Daich Varela , Un Department Of Economic , Lancet Glob Health , Women Health Initiative , Public Health , Jb Lippincott Company , Asia Pacific Ocular Imaging Society , Glob Health , Res Med Sci , Vision Impairment , Global Burden , Clin Med , Vis Sci Technol , Ophthalmol Vis Sci , Rev Dis Primers , Eye Res , Physiol Opt , European Eye , Natl Acad Sci United States , Hum Genet , Retin Eye Res , Diagn Ther , Biomed Opt , Surg Lasers Imaging Retina , Adv Chronic Dis , Englj Med , Arch Clin Exp Ophthalmol ,